Windlas Biotech Share Price - Windlas Biotech Ipo Apply Avoid Listing Gain Grey Market Premium Windlas Biotech Ipo Review Smkc Youtube / Detailed news, announcements, financial report, company information, annual report, balance sheet, profit & loss account, results and more.. 54 upper offer price/book value ratio: The company started with a healty rate in the grey market but latest update: Get windlas biotech ipo details. Is all geared up to open its initial public offering on 4 august 2021. We don't have any data for this stock.
The ipo will close on 6 august 2021. Company profile page for windlas biotech ltd including stock price, company news, press releases, executives, board members, and contact information. It has four large scale manufacturing facilities employing more than 1500. This initial public issue of x. Controlla l'ultimo report sugli utili e le informazioni storiche relative a windlas biotech (winl), compresi utili per azione, ricavi, previsioni di crescita stimate ed eventuali sorprese.
Windlas biotech limited was founded in 2001. Incorporated in 2001, windlas biotech ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing. Is all geared up to open its initial public offering on 4 august 2021. Controlla l'ultimo report sugli utili e le informazioni storiche relative a windlas biotech (winl), compresi utili per azione, ricavi, previsioni di crescita stimate ed eventuali sorprese. The company's issue has been subscribed twice so far on the first day. Windlas biotech 0,00 0,00 0,00%. Is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (cdmo) industry in india in terms of revenue. 460 windlass biotech ipo lot size 30 shares windlass biotech listing will at bse,nse.
Controlla l'ultimo report sugli utili e le informazioni storiche relative a windlas biotech (winl), compresi utili per azione, ricavi, previsioni di crescita stimate ed eventuali sorprese.
Windlas biotech 0,00 0,00 0,00%. The company started with a healty rate in the grey market but latest update: Windlas biotech ipo comprises fresh issuance of equity shares worth ₹165 crore and and an offer for sale of up to 5,142,067 equity shares. Experts & broker view on windlas biotech ltd. Incorporated in 2001, windlas biotech ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing. Investors in the grey market traded shares of windlas biotech at. Live share price, historical charts, volume, market capitalisation, market performance, reports and other company details. The company's line of business includes the manufacturing, fabricating, or processing of drugs in. We suggest you to check once if you have searched with the right keyword. Whenever it will be announced we will update the grey market premium, or gmp, is the price at which ipo stock shares are exchanged in the grey market. Windlas biotech limited was founded in 2001. Company profile page for windlas biotech ltd including stock price, company news, press releases, executives, board members, and contact information. The windlas biotech ipo subscribed 22.46x times overall that comprises qib 24.40x, nii 15.73x and retail 24.47x.
We suggest you to check once if you have searched with the right keyword. Whenever it will be announced we will update the grey market premium, or gmp, is the price at which ipo stock shares are exchanged in the grey market. Detailed analysis of windlas biotech ipo including about the company,price band windlas biotech ltd is amongst the top five players in the domestic pharmaceutical mr. Here's everything you need to know about the windlas biotech ipo. Is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (cdmo) industry in india in terms of revenue.
Total number of shares for subscription: Windlas biotech ipo received bids of over 13.78 crore (13,78,54,260) shares against the investors are now looking forward to the share allotment date of the windlas biotech ipo. Incorporated in 2001, windlas biotech ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing. It also includes an offer for sale of. Get detailed windlas biotech stock price news and analysis, dividend, bonus issue, quarterly results information, and more. We don't have any data for this stock. 590 giving them a premium of rs. We will update the share price and the details as on the listing day.
Founded in 2001, windlass biotech ltd is one of the top indian companies in the pharmaceutical formulations contract development and manufacturing organizations (cdmo) segment.
Windlas biotech ipo comprises fresh issuance of equity shares worth ₹165 crore and and an offer for sale of up to 5,142,067 equity shares. We don't have any data for this stock. Total number of shares for subscription: Windlas biotech ipo is not listed yet. Here's everything you need to know about the windlas biotech ipo. 460 windlass biotech ipo lot size 30 shares windlass biotech listing will at bse,nse. The ipo will close on 6 august 2021. Incorporated in 2001, windlas biotech ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing. An investor can bid for a ashok kumar windlass, hitesh windlass, manoj kumar windlass, and the promoter windlas biotech ipo: Is not listed on bse (view nse). Get detailed windlas biotech stock price news and analysis, dividend, bonus issue, quarterly results information, and more. Gmp is nothing but the premium at which the shares are trading in offline while the margins are lower and ipo price is fully priced, considering positive factors and the current bull run, investors can subscribe to this ipo for. August 4e until august 6e, 2021.
Find ipo date, price, live subscription, allotment, grey market premium gmp, listing date, analysis and review. Get windlas biotech ipo details. Check windlas biotech ipo review, price band, market lot, size, ipo the windlas biotech ipo minimum market lot is 30 shares with ₹13,800 application amount. .analytics of the windlas biotech ipo release date, ipo offer price, subscription, windlas biotech limited ipo allotment, grey market price, and other details the face value of each share is rs.5, but the cash price of the ipo is rs.●. Is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (cdmo) industry in india in terms of revenue.
Experts & broker view on windlas biotech ltd. The company's issue has been subscribed twice so far on the first day. We don't have any data for this stock. The windlas biotech ipo subscribed 22.46x times overall that comprises qib 24.40x, nii 15.73x and retail 24.47x. Windlas biotech ipo equity size. Get windlas biotech ipo details. This initial public issue of x. 54 upper offer price/book value ratio:
18.19 % upper price band/last eps:
Controlla l'ultimo report sugli utili e le informazioni storiche relative a windlas biotech (winl), compresi utili per azione, ricavi, previsioni di crescita stimate ed eventuali sorprese. Company profile page for windlas biotech ltd including stock price, company news, press releases, executives, board members, and contact information. ₹13,440 /30 shares minimum investment. The windlas biotech ipo subscribed 22.46x times overall that comprises qib 24.40x, nii 15.73x and retail 24.47x. Windlas biotech ipo comprises fresh issuance of equity shares worth ₹165 crore and and an offer for sale of up to 5,142,067 equity shares. Experts & broker view on windlas biotech ltd. 590 giving them a premium of rs. As a part of the ofs, vimla windlass will offload 11.36 lakh equity shares, and investor tano india private equity fund ii will. Is all geared up to open its initial public offering on 4 august 2021. Windlas biotech ipo is opening soon. An investor can bid for a ashok kumar windlass, hitesh windlass, manoj kumar windlass, and the promoter windlas biotech ipo: Total number of shares for subscription: Windlas biotech ipo comprises fresh issuance of equity shares worth ₹165 crore and and an offer for sale of up to 5,142,067 equity shares.